{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:49:20Z","timestamp":1791920960531,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bioorg.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T18:17:16Z","timestamp":1549390636000},"page":"420-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"special_numbering":"C","title":["Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors"],"prefix":"10.1016","volume":"86","author":[{"given":"Fikret","family":"Turkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-3157","authenticated-orcid":false,"given":"Muhammet","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lhami","family":"Gul\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioorg.2019.02.013_b0005","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1021\/cr2000459","article-title":"From 2000 to Mid-2010: a fruitful decade for the synthesis of pyrazoles","volume":"111","author":"Fustero","year":"2011","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.013_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10534-011-9496-4","article-title":"Perspective: the potential of pyrazole-based compounds in medicine","volume":"25","author":"Keter","year":"2012","journal-title":"Biometals"},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.013_b0015","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.ejmech.2011.02.052","article-title":"Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening","volume":"46","author":"Ramesh","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2019.02.013_b0020","doi-asserted-by":"crossref","first-page":"10160","DOI":"10.1021\/jf802489e","article-title":"Synthesis and antiviral activities of pyrazole derivatives containing an oxime moiety","volume":"56","author":"Ouyang","year":"2008","journal-title":"J. Agric. Food. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2019.02.013_b0025","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/C7QI00322F","article-title":"A novel environment-friendly hybrid material based on a modified silica gel with a bispyrazole derivative for the removal of Zn II, Pb II, Cd II and Cu II traces from aqueous solutions","volume":"4","author":"Radi","year":"2017","journal-title":"Inorg. Chem. Front."},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.013_b0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jscs.2016.05.008","article-title":"A study on synthesis and antimicrobial activity of 4-acyl-pyrazoles","volume":"22","author":"\u00c7etin","year":"2018","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.02.013_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2017.03.016","article-title":"Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents","volume":"131","author":"Ram\u00edrez-Prada","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2013.08.053","article-title":"Pyrazole containing natural products: synthetic preview and biological significance","volume":"69","author":"Kumar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.013_b0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mrgentox.2012.05.014","article-title":"Evidence of the in vitro genotoxicity of methyl-pyrazole pesticides in human cells","volume":"748","author":"Graillot","year":"2012","journal-title":"Mutat. Res.\/Gen. Toxicol. Environ. Mutag."},{"key":"10.1016\/j.bioorg.2019.02.013_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trac.2016.01.019","article-title":"Applications of a DNA-electrochemical biosensor","volume":"79","author":"Diculescu","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2019.02.013_b0055","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.ejmech.2009.03.038","article-title":"Synthesis and antiviral activity of new pyrazole and thiazole derivatives","volume":"44","author":"El-Sabbagh","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3998\/ark.5550190.p008.131","article-title":"A review of recent progress (2002\u20132012) on the biological activities of pyrazoles","volume":"2014","author":"P\u00e9rez-Fern\u00e1ndez","year":"2013","journal-title":"Arkivoc: Onl. J. Org. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2019.02.013_b0065","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1016\/j.bmc.2009.10.035","article-title":"Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents","volume":"17","author":"Bandgar","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2019.02.013_b0070","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1016\/j.bmc.2010.06.013","article-title":"Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4, 5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents","volume":"18","author":"Insuasty","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.013_b0075","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/molecules20022668","article-title":"Synthesis and evaluation of new 1, 5-diaryl-3-[4-(methyl-sulfonyl) phenyl]-4, 5-dihydro-1h-pyrazole derivatives as potential antidepressant agents","volume":"20","author":"\u00d6zdemir","year":"2015","journal-title":"Molecules"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2019.02.013_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhazmat.2006.12.012","article-title":"Freundlich and Langmuir adsorption isotherms and kinetics for the removal of Tartrazine from aqueous solutions using hen feathers","volume":"146","author":"Mittal","year":"2007","journal-title":"J. Hazard. Mater."},{"issue":"5","key":"10.1016\/j.bioorg.2019.02.013_b0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1081\/CLT-100102445","article-title":"American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad Hoc Committee","volume":"37","author":"Barceloux","year":"1999","journal-title":"Journal of Toxicology Clinical toxicology"},{"issue":"1","key":"10.1016\/j.bioorg.2019.02.013_b0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","article-title":"Ceftolozane\/tazobactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli","volume":"74","author":"Zhanel","year":"2014","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.bioorg.2019.02.013_b0095","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1, 5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1 H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.013_b0100","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/jm040843r","article-title":"Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists","volume":"48","author":"Lange","year":"2005","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2019.02.013_b0105","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0960-894X(96)00323-X","article-title":"Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction","volume":"6","author":"Terrett","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2019.02.013_b0110","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1039\/c3cs60020c","article-title":"sp 2 C-H bond activation in water and catalytic cross-coupling reactions","volume":"42","author":"Li","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"19","key":"10.1016\/j.bioorg.2019.02.013_b0115","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/ol701487g","article-title":"Synthesis of pyridazine-based scaffolds as \u03b1-helix mimetics","volume":"9","author":"Volonterio","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.02.013_b0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/fampra\/cml068","article-title":"Can primary care record review facilitate earlier diagnosis of dementia?","volume":"24","author":"Bamford","year":"2007","journal-title":"Fam Pract."},{"issue":"S1","key":"10.1016\/j.bioorg.2019.02.013_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/14756366.2016.1170014","article-title":"The synthesis of some \u03b2-lactams and investigation of their metal chelating activity, carbonic anhydrase and achetylcholinesterase inhibition profiles","volume":"31","author":"Turan","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2019.02.013_b0130","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ardp.201600183","article-title":"Antioxidant activity, acetylcholinesterase and carbonic anhydrase inhibitory properties of novel ureas derived from phenethylamines","volume":"349","author":"Aksu","year":"2016","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2019.02.013_b0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bioorg.2017.03.001","article-title":"The first synthesis of 4-phenylbutenone derivative bromophenols including natural products and their inhibition profiles for carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase enzymes","volume":"72","author":"Bayrak","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bioorg.2017.07.010","article-title":"Novel antioxidant bromophenols with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions","volume":"74","author":"\u00d6zta\u015fk\u0131n","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molstruc.2017.11.079","article-title":"2-Hydroxyethyl substituted NHC precursors: synthesis, characterization, crystal structure and carbonic anhydrase, \u03b1-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties","volume":"1155","author":"Erdemir","year":"2018","journal-title":"J. Mol. Struct."},{"issue":"8","key":"10.1016\/j.bioorg.2019.02.013_b0150","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.bmc.2009.01.067","article-title":"Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols","volume":"17","author":"\u015eent\u00fcrk","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2019.02.013_b0155","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1016\/j.bmc.2009.07.019","article-title":"Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV","volume":"17","author":"Coban","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.013_b0160","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.bmc.2010.01.076","article-title":"Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids","volume":"18","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2019.02.013_b0165","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1016\/j.bmcl.2010.07.038","article-title":"Carbonic anhydrase inhibitors. Antioxidant polyphenol natural products effectively inhibit mammalian isoforms I-XV","volume":"20","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.013_b0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1747-0285.2011.01104.x","article-title":"In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds","volume":"77","author":"\u015eent\u00fcrk","year":"2011","journal-title":"Chem. Biol. Drugs Des."},{"issue":"14","key":"10.1016\/j.bioorg.2019.02.013_b0175","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.bmcl.2011.05.071","article-title":"In vitro inhibition of \u03b1-carbonic anhydrase isozymes by some phenolic compounds","volume":"21","author":"\u00d6zt\u00fcrk Sar\u0131kaya","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.013_b0180","first-page":"408","article-title":"Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors","volume":"13","author":"G\u00fcl\u00e7in","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2019.02.013_b0185","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bmc.2013.01.019","article-title":"Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors","volume":"21","author":"Ak\u0131nc\u0131o\u011flu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2019.02.013_b0190","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.bmc.2013.03.077","article-title":"Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine","volume":"21","author":"Aksu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0195","doi-asserted-by":"crossref","DOI":"10.1007\/s00396-018-4342-7","article-title":"A novel oligo-pyrazole based thin film: synthesis, characterization, optical and morphological properties","author":"Cetin","year":"2018","journal-title":"Colloid Polym."},{"issue":"7","key":"10.1016\/j.bioorg.2019.02.013_b0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/13543776.2018.1487400","article-title":"Sulfonamide inhibitors: a patent review 2013-present","volume":"28","author":"Gul\u00e7in","year":"2018","journal-title":"Exp. Opin. Therap. Pat."},{"issue":"27","key":"10.1016\/j.bioorg.2019.02.013_b0205","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1002\/slct.201801019","article-title":"Novel benzylic substituted imidazolinium, tetrahydropyrimidinium and tetrahydrodiazepinium salts-potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"3","author":"Yi\u011fit","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2019.02.013_b0210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bioorg.2019.01.044","article-title":"Mono- or di-substituted imidazole derivatives for inhibiton of acetylcholine and butyrylcholine esterases","volume":"86","author":"Kuzu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sajb.2018.04.001","article-title":"In vitro antioxidant, antimicrobial, anticholinesterase and antidiabetic activities of Turkish endemic Achillea cucullata (Asteraceae) from ethanol extract","volume":"120","author":"Eruygur","year":"2019","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.bioorg.2019.02.013_b0220","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molstruc.2018.08.063","article-title":"Synthesis, characterization, crystal structures, theoretical calculations and biological evaluations of novel substituted tacrine derivatives as cholinesterase and carbonic anhydrase enzymes inhibitors","volume":"1176","author":"\u00d6kten","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2019.02.013_b0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bioorg.2018.08.003","article-title":"Novel thymol bearing oxypropanolamine derivatives as potent some metabolic enzyme inhibitors-their antidiabetic, anticholinergic and antibacterial potentials","volume":"81","author":"Zengin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/14756366.2014.1003216","article-title":"Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II","volume":"31","author":"Salmas","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2019.02.013_b0235","doi-asserted-by":"crossref","first-page":"e1700198","DOI":"10.1002\/ardp.201700198","article-title":"Synthesis and carbonic anhydrase inhibition of tetrabromo chalcone derivatives","volume":"350","author":"Kocyigit","year":"2017","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2019.02.013_b0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bioorg.2017.11.015","article-title":"Sulfonamides containing curcumin scaffold: Synthesis, characterization, carbonic anhydrase inhibition and molecular docking studies","volume":"76","author":"Ahmed","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molstruc.2018.02.107","article-title":"Development of selective QSAR models and molecular docking study for inhibitory activity of sulfonamide derivatives against carbonic anhydrase isoforms II and IX","volume":"1163","author":"Yorulmaz","year":"2018","journal-title":"J. Mol. Struct."},{"issue":"10","key":"10.1016\/j.bioorg.2019.02.013_b0250","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/acsmedchemlett.8b00352","article-title":"Tuning the dual inhibition of carbonic anhydrase and cyclooxygenase by dihydrothiazole benzensulfonamides","volume":"9","author":"Meleddu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.02.013_b0255","doi-asserted-by":"crossref","first-page":"14921","DOI":"10.1038\/s41598-018-33354-6","article-title":"Identification of novel acetylcholinesterase inhibitors designed by pharmacophore based virtual screening, molecular docking and bioassay","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2019.02.013_b0260","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-018-3751-3","article-title":"Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: examination by NMR and docking simulations","volume":"24","author":"Tanoli","year":"2018","journal-title":"J. Mol. Model."},{"issue":"4","key":"10.1016\/j.bioorg.2019.02.013_b0265","first-page":"259","article-title":"Phytotoxic activity in pyrazole derivatives","volume":"40","author":"Bernard","year":"1985","journal-title":"Farmaco"},{"issue":"3","key":"10.1016\/j.bioorg.2019.02.013_b0270","doi-asserted-by":"crossref","first-page":"e12516","DOI":"10.1111\/jfbc.12516","article-title":"Antioxidant and anticholinergic properties of olivetol","volume":"42","author":"Taslimi","year":"2018","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bioorg.2018.12.035","article-title":"Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and \u03b1-glycosidase inhibitors","volume":"85","author":"Burmao\u011flu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0280","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bioorg.2018.12.012","article-title":"The first synthesis, carbonic anhydrase inhibition and anticholinergic activities of some bromophenol derivatives with including natural products","volume":"85","author":"Bayrak","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0285","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bioorg.2018.12.028","article-title":"Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity","volume":"84","author":"Ozmen Ozg\u00fcn","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2018.11.001","article-title":"Synthesis, characterization, crystal structure of novel bis-thiomethylcyclohexanone derivatives and their inhibitory properties against some metabolic enzymes","volume":"82","author":"Bi\u00e7er","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0300","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bioorg.2018.09.013","article-title":"New azafluorenones with cytotoxic and carbonic anhydrase inhibitory properties: 2-Aryl-4-(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-ones","volume":"81","author":"Tu\u011frak","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2019.02.013_b0305","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.bmc.2014.04.007","article-title":"Oxidation of cyanobenzocycloheptatrienes: synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives","volume":"22","author":"G\u00fcney","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bioorg.2014.07.009","article-title":"Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies","volume":"56","author":"G\u00f6ksu","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.02.013_b0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.013_b0320","doi-asserted-by":"crossref","first-page":"e1800292","DOI":"10.1002\/ardp.201800292","article-title":"Aminopyrazole-substituted metallophthalocyanines: preparation, aggregation behavior and investigation of metabolic enzymes inhibition properties","volume":"352","author":"G\u00fczel","year":"2019","journal-title":"Arch. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2019.02.013_b0325","doi-asserted-by":"crossref","first-page":"e1800317","DOI":"10.1002\/ardp.201800317","article-title":"Synthesis, crystal structure, and biological evaluation of optically active 2-amino-4-aryl-7,7-dimethyl-5-oxo- 5,6,7,8-tetrahydro-4h-chromen-3-carbonitriles: antiepileptic, antidiabetic, and anticholinergics potentials","volume":"352","author":"Maharramov","year":"2019","journal-title":"Arch. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2019.02.013_b0330","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cbdd.13149","article-title":"Synthesis, molecular modeling and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulfonamides towards acetylcholinesterase, carbonic anhydrase I and II enzymes","volume":"91","author":"Yamali","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2019.02.013_b0335","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molstruc.2018.05.077","article-title":"Synthesis characterization and crystal structure of 2-(4-hydroxyphenyl)ethyl and 2-(4-nitrophenyl)ethyl substituted benzimidazolium bromide salts: their inhibitory properties against carbonic anhydrase and acetylcholinesterase","volume":"1170","author":"Behcet","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2019.02.013_b0340","unstructured":"L. Schr\u00f6dinger, Drug Discov. Suite, 2017."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818314202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818314202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T12:24:05Z","timestamp":1662899045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818314202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":68,"alternative-id":["S0045206818314202"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.013","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}